Skip to main content
PMC home page
The AAPS Journal logoLink to The AAPS Journal
. 2006 Jun 16;8(2):E425–E432. doi: 10.1007/BF02854916

Endocannabinoid signaling directs periimplantation events

Haibin Wang 1, Huirong Xie 1, Sudhansu K Dey 1,✉
PMCID: PMC3231559  PMID: 16808046

Abstract

An emerging concept in female reproduction is the role of endocannabinoids, a group of endogenously produced lipid mediators that bind to and activate cannabinoid receptors. Although adverse effects of cannabinoids in female reproduction have been implicated for years, the mechanisms by which they exert these effects remained elusive. With the identification of cannabinoid receptors, endocannabinoid ligands, their key synthetic and hydrolytic pathways, and the generation of knockout mouse models for cannabinoid receptors, a wealth of information is now available regarding the significance of cannabinoid/endocannabinoid signaling in early pregnancy. This review focuses on various aspects of endocannabinoid signaling in preimplantation embryo development and activation, and uterine differentiation during the periimplantation embryouterine dialog. It is hoped that a deeper understanding will lead to potential clinical applications of the endocannabinoid system as a target for regulating female fertility.

Keywords: cannabinoid/endocannabinoid, embryo development, embryo oviductal transport, implantation, mouse

Full Text

The Full Text of this article is available as a PDF (620.7 KB).

References

  • 1.Dey SK, Lim H, Das SK, et al. Molecular cues to implantation. Endocr Rev. 2004;25:341–373. doi: 10.1210/er.2003-0020. [DOI] [PubMed] [Google Scholar]
  • 2.Paria BC, Reese J, Das SK, Dey SK. Deciphering the cross-talk of implantation: advances and challenges. Science. 2002;296:2185–2188. doi: 10.1126/science.1071601. [DOI] [PubMed] [Google Scholar]
  • 3.Wang H, Dey SK. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet. 2006;7:185–199. doi: 10.1038/nrg1808. [DOI] [PubMed] [Google Scholar]
  • 4.Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med. 2001;345:1400–1408. doi: 10.1056/NEJMra000763. [DOI] [PubMed] [Google Scholar]
  • 5.Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319:189–194. doi: 10.1056/NEJM198807283190401. [DOI] [PubMed] [Google Scholar]
  • 6.Carson DD, Bagchi I, Dey SK, et al. Embryo implantation. Dev Biol. 2000;223:217–237. doi: 10.1006/dbio.2000.9767. [DOI] [PubMed] [Google Scholar]
  • 7.Red-Horse K, Zhou Y, Genbacev O, et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest. 2004;114:744–754. doi: 10.1172/JCI22991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561–564. doi: 10.1038/346561a0. [DOI] [PubMed] [Google Scholar]
  • 9.Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61–65. doi: 10.1038/365061a0. [DOI] [PubMed] [Google Scholar]
  • 10.Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258:1946–1949. doi: 10.1126/science.1470919. [DOI] [PubMed] [Google Scholar]
  • 11.Sugiura T, Kondo S, Sukagawa A, et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun. 1995;215:89–97. doi: 10.1006/bbrc.1995.2437. [DOI] [PubMed] [Google Scholar]
  • 12.Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 1997;388:773–778. doi: 10.1038/42015. [DOI] [PubMed] [Google Scholar]
  • 13.Das SK, Paria BC, Chakraborty I, Dey SK. Cannabinoid ligand-receptor signaling in the mouse uterus. Proc Natl Acad Sci USA. 1995;92:4332–4336. doi: 10.1073/pnas.92.10.4332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Paria BC, Das SK, Dey SK. The preimplation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc Natl Acad Sci USA. 1995;92:9460–9464. doi: 10.1073/pnas.92.21.9460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Paria BC, Song H, Wang X, et al. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J Biol Chem. 2001;276:20523–20528. doi: 10.1074/jbc.M100679200. [DOI] [PubMed] [Google Scholar]
  • 16.Wang H, Guo Y, Wang D, et al. Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med. 2004;10:1074–1080. doi: 10.1038/nm1104. [DOI] [PubMed] [Google Scholar]
  • 17.Yang ZM, Paria BC, Dey SK. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development. Biol Reprod. 1996;55:756–761. doi: 10.1095/biolreprod55.4.756. [DOI] [PubMed] [Google Scholar]
  • 18.Paria BC, Ma W, Andrenyak DM, et al. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Biol Reprod. 1998;58:1490–1495. doi: 10.1095/biolreprod58.6.1490. [DOI] [PubMed] [Google Scholar]
  • 19.Rinaldi-Carmona M, Barth F, Heaulme M, et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 1994;350:240–244. doi: 10.1016/0014-5793(94)00773-X. [DOI] [PubMed] [Google Scholar]
  • 20.Rinaldi-Carmona M, Barth F, Millan J, et al. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther. 1998;284:644–650. [PubMed] [Google Scholar]
  • 21.Sharov AA, Piao Y, Matoba R, et al. Transcriptome analysis of mouse stem cells and early embryos. PLoS Biol. 2003;1:e74–e74. doi: 10.1371/journal.pbio.0000074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Incrpased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA. 1999;96:5780–5785. doi: 10.1073/pnas.96.10.5780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Jarai Z, Wagner JA, Varga K, et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA. 1999;96:14136–14141. doi: 10.1073/pnas.96.24.14136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Heilman RD, Reo RR, Hahn DW. Changes in the sensitivity of adrenergic receptors in the oviduct during early gestation in the rabbit. Fertil Steril. 1976;27:426–430. [PubMed] [Google Scholar]
  • 25.Howe GR, Black DL. Autonomic nervous system and oviduct function in the rabbit. I. Hormones and contraction. J Reprod Fertil. 1973;33:425–430. doi: 10.1530/jrf.0.0330425. [DOI] [PubMed] [Google Scholar]
  • 26.Kennedy DR, Marshall JM. Effect of adrenergic nerve stimulation on the rabbit oviduct: correlation with norepinephrine content and turnover rate. Biol Reprod. 1977;16:200–211. doi: 10.1095/biolreprod16.2.200. [DOI] [PubMed] [Google Scholar]
  • 27.Paria BC, Lim H, Wang XN, Liehr J, Das SK, Dey SK. Coordination of differential effects of primary estrogen and catecholestrogen on two distinct targets mediates embryo implantation in the mouse. Endocrinology. 1998;139:5235–5246. doi: 10.1210/en.139.12.5235. [DOI] [PubMed] [Google Scholar]
  • 28.Das SK, Wang XN, Paria BC, et al. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development. 1994;120:1071–1083. doi: 10.1242/dev.120.5.1071. [DOI] [PubMed] [Google Scholar]
  • 29.Yoshinaga K, Adams CE. Delayed implantation in the spayed, progesterone treated adult mouse. J Reprod Fertil. 1996;12:593–595. doi: 10.1530/jrf.0.0120593. [DOI] [PubMed] [Google Scholar]
  • 30.McLaren A. Blastocysts in the mouse uterus: the effect of ovariectomy, progesterone and oestrogen. J Endocrinol. 1971;50:515–526. doi: 10.1677/joe.0.0500515. [DOI] [PubMed] [Google Scholar]
  • 31.Schmid PC, Paria BC, Krebsbach RJ, Schmid HH, Dey SK. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc Natl Acad Sci USA. 1997;94:4188–4192. doi: 10.1073/pnas.94.8.4188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Guo Y, Wang H, Okamoto Y, et al. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J Biol Chem. 2005;280:23429–23432. doi: 10.1074/jbc.C500168200. [DOI] [PubMed] [Google Scholar]
  • 33.Wang J, Paria BC, Dey SK, Armant DR. Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development. Biol Reprod. 1999;60:839–844. doi: 10.1095/biolreprod60.4.839. [DOI] [PubMed] [Google Scholar]
  • 34.Liu WM, Duan EK, Cao YJ. Effects of anandamide on embryo implantation in the mouse. Life Sci. 2002;71:1623–1632. doi: 10.1016/S0024-3205(02)01928-8. [DOI] [PubMed] [Google Scholar]
  • 35.Wang H, Matsumoto H, Guo Y, Paria BC, Roberts RL, Dey SK. Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. Proc Natl Acad Sci USA. 2003;100:14914–14919. doi: 10.1073/pnas.2436379100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Di Marzo V, Fontana A, Cadas H, et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 1994;372:686–691. doi: 10.1038/372686a0. [DOI] [PubMed] [Google Scholar]
  • 37.Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem. 2004;279:5298–5305. doi: 10.1074/jbc.M306642200. [DOI] [PubMed] [Google Scholar]
  • 38.Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 1996;384:83–87. doi: 10.1038/384083a0. [DOI] [PubMed] [Google Scholar]
  • 39.Maccarrone M, DeFelici M, Klinger FG, et al. Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus. Mol Hum Reprod. 2004;10:215–221. doi: 10.1093/molehr/gah034. [DOI] [PubMed] [Google Scholar]
  • 40.Paria BC, Deutsch DD, Dey SK. The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. Mol Reprod Dev. 1996;45:183–192. doi: 10.1002/(SICI)1098-2795(199610)45:2<183::AID-MRD11>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  • 41.Paria BC, Zhao X, Wang J, Das SK, Dey SK. Fatty-acid amide hydrolase is expressed in the mouse uterus and embryo during the periimplantation period. Biol Reprod. 1999;60:1151–1157. doi: 10.1095/biolreprod60.5.1151. [DOI] [PubMed] [Google Scholar]
  • 42.Piomelli D. THC: moderation during implantation. Nat Med. 2004;10:19–20. doi: 10.1038/nm0104-19. [DOI] [PubMed] [Google Scholar]
  • 43.Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agro A. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet. 2000;355:1326–1329. doi: 10.1016/S0140-6736(00)02115-2. [DOI] [PubMed] [Google Scholar]
  • 44.Maccarrone M, Bisogno T, Valensise H, et al. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod. 2002;8:188–195. doi: 10.1093/molehr/8.2.188. [DOI] [PubMed] [Google Scholar]
  • 45.Song H, Lim H, Paria BC, et al. Cytosolic phospholipase A2alpha is crucial for ‘on-time’ embryo implantation that directs subequent development. Development. 2002;129:2879–2889. doi: 10.1242/dev.129.12.2879. [DOI] [PubMed] [Google Scholar]
  • 46.Ye X, Hama K, Contos JJ, et al. LPA 3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature. 2005;435:104–108. doi: 10.1038/nature03505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregancy. N Engl J Med. 1999;340:1796–1799. doi: 10.1056/NEJM199906103402304. [DOI] [PubMed] [Google Scholar]

Articles from The AAPS Journal are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES